|
Live Stream Webinar
ASEAN & China Pharma Markets
Tuesday, 29 June 2021, 4:00-6:00 PM (GMT+8 China Time)
|
|
|
|---|
|
|
|
China and Southeast Asian Countries are important partners and players in the pharmaceutical markets in Asia. With the signing of the Regional Comprehensive Economic Partnership (RCEP), tariffs and barriers reduction among members will further contribute to business cooperation in the regions in a wide range of industries including pharmaceutical, herbal medicines and tech transfer.
Pharma companies who are seeking to entry to China and ASEAN markets may face challenges, require strategic planning in regulatory approval and market access. This webinar will gather 4 experts who will deliver insights into the China pharma industry under the Regional Comprehensive Economic Partnership (RCEP) impact, overcoming the regulatory barriers in majoy Southeast Asian Countries, pharma R&D in major ASEAN markets and etc.
|
|
|
|---|
|
|
- ASEAN-China Market Opportunities with the signing of RCEP to Pharmaceutical Industry
- Pharmaceutical GMP and Regulatory Affairs in Southeast Asia (ASEAN)
- Pharmaceutical Innovation Updates in Thailand
- Pharmaceutical Markets Opportunities in Vietnam
|
|
|
|---|
|
|
|
Ms. He Chun Hong
Director, Dept. of International Cooperation
China Chamber of Commerce for Import and Export of Medicines & Health Products (CCCMHPIE)
|
|
|
|
Ms. He Chun Hong, joined CCCMHPIE in 1994, has been committed to providing pharmaceutical enterprises with information services in the field of international trade and investment, technical and legal services, international exchanges and cooperation. From 1999 to 2003, She served as the Third Secretary and the Second Secretary of the Economic and Commercial Office of the Embassy of the People's Republic of China in the Republic of Indonesia. She has joined many multilateral and bilateral governmental talks between China and key countries, planed and organized major events and international meetings, leaded or participated in the research projects of Ministry of Commerce PRC, National Health Commission, National Development and Reform Commission, NMPA and other national government departments, as well as international organization projects such as Gates Foundation. She has kept work relationship with foreign drug administration agencies, industry organizations and key foreign institutions in China. She plays an active role in promoting the international trade and investment and the construction of the quality system of the pharmaceutical industry.
|
|
|
|---|
|
|
|
Mr. Kenny Peng
Executive VP, Asia
PharmEng Technology, Singapore
|
|
|
|
Kenny Peng has worked in pharmaceutical and biopharmaceutical engineering across North America and Asia, is currently also the Executive VP. and Managing Director, of PharmEng Asia. His regulatory Affairs experiences run across managing multi-billion dolor compliance projects (dossier management) for big pharmaceutical company mergers, bringing new products in the market up to post approval activities. Mr. Peng built a business in regulatory affairs and engineering assisting companies around the world breaking into complex pharmaceutical regulations in Asia, assisting pharmaceutical manufacturers in designing and building modern pharmaceutical facilities. He has worked with many multinational companies within the industry including pre-clinical, clinical, commercial phases, innovation, development manufacturing, and supply chain lifecycle phases. He started his career in biomedical sensor design prior to entering the consulting industry, with pharmaceutical equipment and facility design, and subsequently validation where he led multiple technology transfer projects from North America to Southeast Asia. He has 15 years of experiences including design, build, commission, qualify, and validate facilities in Canada, US, Malaysia, Singapore, Indonesia, Thailand, Korea, and China.
|
|
|
|---|
|
|
|
Mr. Sirasak Teparkum
CEO, Thailand Center of Excellence for Life Sciences (TCELS)
|
|
|
|
Dr.Sirasak Teparkum is the CEO of Thailand Center of Excellence for Life Sciences (TCELS) which aims to drive Thailand as the leader of life science industry in ASEAN and promote life science industry to be one of the top ten highest industry by 2027. He has joined TCELS since 2016 as a Deputy CEO, responsible for research and innovation department including four programs, Bio-Pharmaceutical & Regenerative Medicine Program, Natural Product and Cosmeceutical Program, Medical Device and Medical Robotic Program, and Medicopolis Program. Dr. Sirasak Teparkum had long experience of various technology transfer projects related to nanotechnology translational research, creating both income and economic impacts to Thailand more than seven billion Baht (7,000 Million Baht) and had experiences in top executive management at the national research center including chief of editor of books and journals.
|
|
|
|---|
|
|
|
Ms. Do Thanh Huyen
Assistant Manager of Business Intelligence
Dezan Shira & Associates
|
|
|
|
Do Thanh Huyen has been involved with various site selection, partners and vendor identification and vetting and industrial market opportunity analysis studies. Ms. Huyen has worked well with both MNCs, government agencies and local companies in variety of sector including manufacture, agriculture, electronics, F&B and other services sectors. Having spent several years in Germany and therefore skilled in German, Huyen plays a key role in the firm's German Desk in Vietnam for which she nurtures and develops local partnerships with the German business partners community, coordinates German language publications and is point of contact for all German speaking clients interested in doing business in Vietnam.
|
|
|
|---|
|
|
|
CPhI & P-MEC China E-Trade Season 2021
|
|
|
|---|
|
|
|
.png){kind=logo}
